• Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

A5Y:GR

0.086 EUR 0.011 14.67%

As of 10:46:23 ET on 07/29/2014.

Snapshot for Affymax Inc (A5Y)

Open: 0.064 Day's Range: 0.064 - 0.086 Volume: 2,600
Previous Close: 0.075 52wk Range: 0.060 - 1.468 1-Yr Rtn: -93.38%

Stock Chart for A5Y

No chart data available.
  • A5Y:GR 0.086
  • 1D
  • 1M
  • 1Y
0.075
Interactive A5Y Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for A5Y

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 3.22
Shares Outstanding (M) 37.49
30 Day Average Volume 5,633
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for A5Y

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for A5Y

Affymax Inc. is a clinical-stage biopharmaceutical company. The Company develops peptide-based drugs for the treatment of serious and life-threatening conditions such as kidney disease and cancer.

Richard M Brenner "Rich"Chief Executive OfficerJ Weston Rose "Wes"President
Mark G ThompsonChief Financial Officer
More Company Profile & Key Executives for A5Y

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil